Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Committed to ‘Serve Health Care Needs Worldwide’ , we produce a comprehensive range of specialty products targeting different therapeutic segments for treatment of patients, customised to each market we are present in. We clearly understand our customer’s needs and use cutting edge technology to present innovative solutions. Our business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia. In India we have presence in high growth specialty segments of cardiology, dermatology, ophthalmology and pain management where we have been able to provide consistently innovative products, many being 1 st to the market , for patient convenience and compliance.
We are gradually building a meaningful presence in the US market with select product portfolio, which include complex technology products to get the competitive advantage in the market place. We expect US market to be our key growth driver in the coming years.
Ajanta operates 7 state-of-the-art manufacturing facilities in India and Mauritius. 2 of the facilities in India have been successfully approved by US FDA . We are further expanding our manufacturing capabilities to meet our growth requirement in future.
We have an advanced Research & Development Centre for finished formulations and Active Pharmaceutical Ingredient (API) synthesis of different dosage forms. Our R a commitment to ‘Serving Global Healthcare needs with Empathy, Innovation & Technology’.